Pfizer completes Haleon exit with £2.5bn stake sale
Pfizer has raised £2.5 billion by offloading its remaining 7.3% stake in Haleon, the Panadol and Sensodyne business it used ...
Pfizer offloads final shares in Sensodyne maker Haleon
Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US ...
Pfizer sells entire Haleon stake for $3.24 billion
Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...
Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion
Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...
City snapshot: Pfizer completes £2.5bn Haleon exit
Pfizer still owns about 7.3% of the company making it the largest shareholder. GSK sold its remaining stake in May last year.
German Doner Kebab boss wants to turn chain into date-worthy dinner spot
GERMAN DONER KEBAB boss Simon Wallis is on a mission to transform the food from “something you eat at 2am after 12 pints of ...
London Stock Exchange off to a flying start in 2025 as confidence returns to the City: MAGGIE PAGANO
Two companies have already listed on the main London Stock Exchange in 2025 while five new entrants have joined AIM, the ...
The Business Times16h
Pfizer sells entire Haleon stake for US$3.24 billion
Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the ...